IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ethier, C. R.
Right arrow Articles by Chan, D. W.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ethier, C. R.
Right arrow Articles by Chan, D. W.-H.
(Investigative Ophthalmology and Visual Science. 2001;42:1795-1802.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Cationic Ferritin Changes Outflow Facility in Human Eyes Whereas Anionic Ferritin Does Not

C. Ross Ethier1,2 and Darren W.-H. Chan1

1 From the Departments of Mechanical and Industrial Engineering and 2 Ophthalmology, University of Toronto, Ontario, Canada.

PURPOSE. To determine the effect of charged moieties within the outflow pathway on aqueous outflow facility in human eyes.

METHODS. After baseline facility measurement in human eye bank eyes (n = 10 pairs), one eye of each pair received anterior chamber exchange and continued perfusion with medium containing 10 mg/ml cationic ferritin. Contralateral eyes were treated in a similar manner with anionic ferritin (10.0 or 102 mg/ml). Eyes were fixed by anterior chamber exchange and perfusion with universal fixative at 8 mm Hg (corresponding to a physiologic pressure of 15 mm Hg in vivo) and examined by transmission electron microscopy. In a second series of human eyes (n = 8 pairs), facility was measured before and after anterior chamber exchange, with a solution containing 0.1 U/ml neuraminidase.

RESULTS. Perfusion of eyes with anionic ferritin at either 10.0 or 102 mg/ml caused a negligible 2% increase in facility, whereas cationic ferritin perfusion reduced facility by 66% (P < 0.00001). Perfusion with fixative reduced facility by approximately 60% in both cationic and anionic ferritin-perfused eyes, relative to facilities after perfusion with ferritin. Transmission electron microscopy showed that the distribution of ferritin was segmentally variable. Cationic ferritin consistently labeled the luminal surface of the inner wall of Schlemm’s canal, and variably labeled the juxtacanalicular connective tissue (JCT) and trabecular beam surfaces. Anionic ferritin was more prominent in the JCT and intertrabecular spaces and less so on the luminal surface of Schlemm’s canal. By scanning electron microscopy, cationic ferritin was seen to accumulate at intercellular margins of the inner wall. Neuraminidase perfusion had no significant effect on outflow facility.

CONCLUSIONS. Cationic ferritin reduces outflow facility, presumably by binding to negatively charged sites in the outflow pathway. A possible mechanism is partial or complete blockage of intercellular clefts in the inner wall of Schlemm’s canal by the ferritin that accumulates on the luminal surface of the inner wall. Although they are possible targets for ferritin binding, sialyl residues themselves seem to have little direct effect on outflow facility. Our data indicate that positively charged molecules, especially if they can interact with inner wall pores, have the potential to markedly alter outflow facility.




This article has been cited by other articles:


Home page
IOVSHome page
S. A. Battista, Z. Lu, S. Hofmann, T. Freddo, D. R. Overby, and H. Gong
Reduction of the Available Area for Aqueous Humor Outflow and Increase in Meshwork Herniations into Collector Channels Following Acute IOP Elevation in Bovine Eyes
Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5346 - 5352.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. E. Keller, J. M. Bradley, M. J. Kelley, and T. S. Acott
Effects of Modifiers of Glycosaminoglycan Biosynthesis on Outflow Facility in Perfusion Culture
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2495 - 2505.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. R. Hann, C. K. Bahler, and D. H. Johnson
Cationic Ferritin and Segmental Flow through the Trabecular Meshwork
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. R. Ethier, A. T. Read, and D. Chan
Biomechanics of Schlemm's Canal Endothelial Cells: Influence on F-Actin Architecture
Biophys. J., October 1, 2004; 87(4): 2828 - 2837.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. K. Bahler, C. R. Hann, M. P. Fautsch, and D. H. Johnson
Pharmacologic Disruption of Schlemm's Canal Cells and Outflow Facility in Anterior Segments of Human Eyes
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2246 - 2254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. A. Alvarado, A. Betanzos, L. Franse-Carman, J. Chen, and L. Gonzalez-Mariscal
Endothelia of Schlemm's canal and trabecular meshwork: distinct molecular, functional, and anatomic features
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C621 - C634.
[Abstract] [Full Text]


Home page
IOVSHome page
M. Johnson, D. Chan, A. T. Read, C. Christensen, A. Sit, and C. R. Ethier
The Pore Density in the Inner Wall Endothelium of Schlemm's Canal of Glaucomatous Eyes
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2950 - 2955.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology